We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 680 results
  1. Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms?

    Background

    Switching to aripiprazole from other antipsychotics can avoid antipsychotic-induced hyperprolactinemia but may result in an abnormally low...

    Ya-Wen Jen, Tzung-Jeng Hwang, ... Wei J. Chen in BMC Psychiatry
    Article Open access 23 November 2020
  2. Psychosis secondary to thyrotoxicosis that persisted post-thyroidectomy: a case report

    Background

    This case report is of a patient with psychosis secondary to thyrotoxicosis that persisted and reemerged after definitive treatment of...

    Shiva Kothari, William Townsend, ... Kevin Freeman in BMC Psychiatry
    Article Open access 13 October 2023
  3. Psychiatric Emergencies in Los Angeles County During, and After, Initial COVID-19 Societal Restrictions: An Interrupted Time-Series Analysis

    Emergency department (ED) visits for psychiatric care in the US reportedly declined during the COVID-19 pandemic. This work, however, does not...

    Tim A. Bruckner, Shutong Huo, ... Annie Ro in Community Mental Health Journal
    Article Open access 12 December 2022
  4. Challenges and opportunities in the diagnosis and treatment of early-onset psychosis: a case series from the youth affective disorders clinic in Stockholm, Sweden

    Early-onset psychosis is linked to adverse long-term outcomes, recurrent disease course, and prolonged periods of untreated illness; thus...

    Mathias Lundberg, Peter Andersson, ... Adrian E. Desai Boström in Schizophrenia
    Article Open access 03 January 2024
  5. Amisulpride withdrawal akathisia responding to aripiprazole with propranolol in first-onset psychosis: a case report

    Background

    Akathisia tends to develop as an early complication of antipsychotic treatment in a dose-dependent manner. Although withdrawal akathisia...

    Hae-Jung Yang, Seung-Gon Kim, ... Hyung-Jun Yoon in BMC Psychiatry
    Article Open access 29 January 2022
  6. Pharmacotherapy for ADHD in children and adolescents: A summary and overview of different European guidelines

    Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by a persistent pattern of inattention, hyperactivity,...

    L. Van Vyve, B. Dierckx, ... T. Banaschewski in European Journal of Pediatrics
    Article 14 December 2023
  7. Thiamazole

    Article 25 May 2024
  8. Paliperidone

    Article 21 October 2023
  9. Interruptions in HIV and Behavioral Health Care for Criminal-Legal Involved People Living with HIV Following Implementation of Decarceration and Shelter in Place in San Francisco, California

    Decarceration policies, enacted for SARS-CoV-2 mitigation in carceral settings, potentially exacerbated barriers to care for people living with HIV...

    A. Asa Clemenzi-Allen, Jillian Hebert, ... Paul Wesson in AIDS and Behavior
    Article Open access 07 December 2023
  10. Stimulant treatment effectiveness, safety and risk for psychosis in individuals with 22q11.2 deletion syndrome

    This study aimed to retrospectively evaluate an association between stimulant treatment for attention-deficit/hyperactivity disorder (ADHD) in...

    Dana Basel, Mariela Mosheva, ... Doron Gothelf in European Child & Adolescent Psychiatry
    Article 19 April 2021
  11. The effects of social isolation stress and discrimination on mental health

    Social isolation and discrimination are growing public health concerns associated with poor physical and mental health. They are risk factors for...

    Lasse Brandt, Shuyan Liu, ... Andreas Heinz in Translational Psychiatry
    Article Open access 21 September 2022
  12. Multiple drugs

    Article 29 June 2024
  13. Clozapine

    Article 18 November 2023
  14. Antipsychotics

    Article 11 June 2022
  15. Giant cabergoline-resistant prolactinoma in a man who presented with a psychotic episode during treatment: a case report

    Background

    Prolactinomas are tumors of the pituitary gland that usually respond very well to treatment with cabergoline. Resistance to cabergoline is...

    Luiz Augusto Casulari, Lucas Faria de Castro, ... Maria de Fátima Magalhães Gonzaga in Journal of Medical Case Reports
    Article Open access 16 June 2019
  16. Clozapine

    Article 17 December 2022
  17. Antipsychotics

    Article 02 April 2022
Did you find what you were looking for? Share feedback.